PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27928738-0	2017	Effect of Multiple Oral Doses of the Potent CYP3A4 Inhibitor Clarithromycin on the Pharmacokinetics of a Single Oral Dose of Vonoprazan: A Phase I, Open-Label, Sequential Design Study.	Clarithromycin	61-75	cytochrome P450 family 3 subfamily A member 4	Homo sapiens	44-50	
27928738-11	2017	CONCLUSIONS: Modest increases in plasma concentrations of the potent CYP3A4 inhibitor clarithromycin and vonoprazan were observed during coadministration, however these differences were not considered clinically significant.	Clarithromycin	86-100	cytochrome P450 family 3 subfamily A member 4	Homo sapiens	69-75